Divalproex Sodium Tablet, Delayed Release
Product Images NDC 70518-3431

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-3431). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Divalproex Sodium 250mg 70518 3431 01)

Divalproex Sodium 250 mg delayed-release oral tablets packaging label, quantity 30 tablets. The label includes NDC 70518-3431-01, manufacturer Sun Pharma, and repackager RemedyRepack Inc. Directions indicate a package insert for use, with storage instructions at 20-25°C and allowance for excursions. Includes barcode and QR code.*

FDA Label Image

Divalproex Sodium 250mg 70518 3431 02

Label for Divalproex Sodium 250 mg delayed-release tablets. The package contains 100 tablets. The label indicates Rx only status, manufacturer as Sun Pharma, Cranbury, NJ, and repackaging by RemedyRepack Inc. Includes barcodes and a note to keep medication out of reach of children.*

FDA Label Image

Divalproex Sodium 250mg 70518 3431 03

Label for Divalproex Sodium 250 mg delayed-release oral tablet, quantity of 1. The label includes dosage strength, formulation, and manufacturer details, including repackaging by RemedyRepack Inc., Indiana, PA. It also features barcodes, a QR code, and storage instructions.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Divalproex Sodium delayed-release tablets, 250 mg strength, with a quantity of 60 tablets. The label includes Rx only designation, NDC number 70518-3431-00, manufacturer Sun Pharma in Cranbury, NJ, and repackager RemedyRepack Inc. The label instructs to see the package insert for usage directions and includes storage temperature guidelines. The RemedyRepack logo is visible.*

FDA Label Image

Spl-divalproex-figure-1 (Spl Divalproex Figure 1)

Bar graph labeled Figure 1 comparing percentage values for PBO versus DVPX in two studies. Study 1 uses YMRS and shows 26% for PBO and 60% for DVPX. Study 2 uses MRS and shows 29% for PBO and 58% for DVPX. The y-axis displays percentages from 0% to 70%.*

FDA Label Image

Spl-divalproex-figure-2 (Spl Divalproex Figure 2)

A line chart titled Figure 2 showing the percentage reduction in CPS rate on the y-axis versus the percentage of patients on the x-axis. The chart compares two groups: Divalproex Sodium (DVPX) and Placebo. Improvement and worsening directions are indicated along the y-axis, with Divalproex Sodium showing a higher percentage of patients with greater reduction than Placebo.*

FDA Label Image

Spl-divalproex-figure-3 (Spl Divalproex Figure 3)

A line graph titled Figure 3 illustrating the percentage reduction in CPS (Clinical Pain Score) rate versus percentage of patients. The graph compares two treatment groups: High Dose (solid line) and Low Dose (dashed line). The y-axis shows percentage reduction in CPS rate from -100% to 100%, with labels indicating worsening at the bottom, no change at zero, and improvement at the top. The x-axis shows percentage of patients from 0 to 100%. Both lines depict changes in CPS rates across patient percentages.*

FDA Label Image

Spl-divalproex-figure-4 (Spl Divalproex Figure 4)

Bar chart titled 'Figure 4 Mean 4-week Migraine Rates' comparing migraine rates between placebo and Divalproex Sodium (DVPX) groups across two studies. The vertical axis shows migraine rates ranging from 0 to 6. Study 1 shows higher rates for placebo than DVPX; Study 2 also shows higher placebo rates compared to DVPX.*

FDA Label Image

Spl-divalproex-structure (Spl Divalproex Structure)

Chemical structure of divalproex sodium, showing the sodium ion complexed with two valproate molecules and the polymeric repeating unit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.